^
    Apply
    First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation (NCT04006301)
    Phase 1
    Janssen Research & Development, LLC
    Completed
    Last update posted :
    11/06/2020
    Initiation :
    07/26/2019
    Primary completion :
    07/13/2020
    Completion :
    07/13/2020
    KRAS
    |
    KRAS G12C • KRAS G12
    |
    JNJ-74699157